Previous researches verified that F2RL2 can be targeted by miR-429 and miR-483-3p in colorectal cancer and anaplastic thyroid cancer [17, 18]. This evidence concerns the gene F2RL2 and thyroid gland undifferentiated (anaplastic) carcinoma.